Willis Re appoints head of Willis Re Specialty Analytics

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Willis Re appoints head of Willis Re Specialty Analytics

LONDON, Oct. 05, 2016 (GLOBE NEWSWIRE) -- Willis Re today announces the appointment of Printhan Sothinathan as Managing Director, Head of Willis Re Specialty Analytics. Sothinathan will begin his role in January 2017 and will report to Graeme Moore, Chief Executive Officer of Willis Re Global Specialty.

Sothinathan will be leading the expansion and development of the Willis Re Specialty Analytics service offering to clients. He joins from the Navigators Group where he was Managing Director of Continental Europe. His broad (re)insurance career spans 20 years, during which he has gained extensive experience from multi-sized companies across the UK, European and US markets.

Commenting on his appointment, Sothinathan said: “I am excited to be joining Willis Re Specialty at a time when the team is actively enhancing its service capability in the face of a rapidly changing marketplace to better serve its clients. Willis Re Specialty is a premier broker that has grown its market share over the past two years. It has augmented and retained its intellectual capital, further proving its commitment to clients. I am tremendously looking forward to adding to the success of Willis Re and serving its clients’ needs now and in the future.”

Graeme Moore, CEO of Willis Re Global Specialty said : “'The addition of Printhan to our growing and talented team is an exciting strategic development for Willis Re Specialty, combining our transactional excellence with a forward thinking and proactive analytical approach.

"As the reinsurance market and our clients evolve it is essential that our offering embodies the full suite of analytics, instead of the traditional model of being supported by analytics. Printhan already has a proven track record in this area and we are delighted to have him on board.”

ABOUT SOTHINATHAN : Sothinathan began his career in 2001 at Tillinghast Towers Perrin before joining Zurich in 2003 as a pricing actuarial analyst. He joined the Navigators Group in 2006 as vice president of marine & energy ceded reinsurance. In 2009, he was appointed group chief strategy officer of Torus (now StarStone). He has held his current position as managing director of continental Europe and UK Branch at the Navigators Group since 2014.

ABOUT WILLIS RE  One of the world's leading reinsurance brokers, Willis Re is known for its world-class analytics capabilities, which it combines with its reinsurance expertise in a seamless, integrated offering that can help clients increase the value of their businesses. Willis Re serves the risk management and risk transfer needs of a diverse, global client base that includes all of the world's top insurance and reinsurance carriers as well as national catastrophe schemes in many countries around the world. The broker's global team of experts offers services and advice that can help clients make better reinsurance decisions and negotiate optimum terms. For more information, visit willisre.com .

ABOUT WILLIS TOWERS WATSON Willis Towers Watson (NASDAQ: WLTW ) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has 39,000 employees in more than 120 territories. We design and deliver solutions that manage risk, optimize benefits, cultivate talent, and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com.

CONTACT MEDIA Annie Roberts: +44 20 3124 7080 | Annie.Roberts@willistowerswatson.com INVESTORS Aida Sukys: +1 703 258 8033 | Aida.Sukys@willistowerswatson.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Invesco's Q3 2026: A Balance of Growth and Caution

Updated Category News Views 18

Examining Invesco's Q3 Financial Dance Invesco Ltd. (NYSE: IVZ) decided to break it down this quarter, serving up numbers that might just look like a mixed bag if you're not keeping a keen eye on the game's subtleties. The spotlight's on their third-quarter performance, brandishing a diluted EPS of $0.65 and adjusted diluted EPS of $0.72. Invesco's AUM Strikes Highs...

Continue Reading
Implantica's Strategic U.S. Entry with RefluxStop®

Updated Category News Views 136

Implantica's Ambitious Move into the U.S. Market Every now and then, a move in the medtech sector grabs everyone's attention, and that's what we got with Implantica's latest play. This company is pulling out the big guns to push its RefluxStop® device into the U.S. market—one of the toughest nuts to crack. They've roped in Dr. John C. Lipham, a leading U.S. surgeon, to...

Continue Reading
IBSSC 2026: A New Chapter in Business Education

Updated Category News Views 96

Shifts in Business Education at the IBSSC 2026 Boy, oh boy, Shanghai was buzzing the other week. We’re diving into the heart of the 11th International Business School Shanghai Conference (IBSSC). There's a changing of the guard in how business education is viewed, and it was all happening from October 21 to 23 at the Xuhui campus of Shanghai Jiao Tong University. Global...

Continue Reading
CMS Energy's Q3 Marks Change: Restructuring Boost

Updated Category News Views 71

A Tale of Two Earnings Few things get my blood pumping like a new quarter's earnings dance, and CMS Energy (NYSE:CMS) is stealing the show right now with its two-faced Q3 results. Digging deep into the numbers, we see this Michigan-based energy player reporting a gauntlet of figures that have investors raising their eyebrows. On one hand, reported GAAP earnings dropped to...

Continue Reading
Atrium's ATR 1072 Doses First in Genetic Cardiomyopathy Trial

Updated Category News Views 44

Atrium's Leap in Genetic Cardiomyopathy You know you're living in fascinating times when a company like Atrium Therapeutics rolls the dice on RNA therapeutics, aiming to tackle heart diseases at the genetic level. And that's precisely what they did! They just dosed the first patient in the Phase 1/2 Corventis trial with their drug ATR 1072, setting sail on uncharted...

Continue Reading
Investors Shaken by Better Home’s 28.5% Plunge

Updated Category News Views 45

Pull up a chair, because Better Home & Finance Holding Company (NASDAQ: BETR) just threw its investors into a frenzy. Mayhem hit when their stock nosedived 28.5% on a single day—May 7, 2026. Let’s untangle what happened and why every shareholder should circle November 20 on their calendar. Unpacking the Fall: A Dive Into Hard Truths So, between mid-March and early May...

Continue Reading
Tamara Toles O'Laughlin: Steering Philanthropy's Next Era

Updated Category News Views 91

Leadership Transition in Philanthropy Everyone knows the drill: leadership changes are often a toss-up. You could get a fresh burst of energy or spend years longing for the good old days. That's where The New York Women's Foundation finds itself as they hand over the reins from Ana L. Oliveira to Tamara Toles O'Laughlin. In a world where philanthropic shifts can either...

Continue Reading
ALHC Faces Fraud Probe After 16% Stock Plummet

Updated Category News Views 47

Investors Eye Alignment's Tumultuous Turn One thing I don't do is sugarcoat it—stocks get hit hard sometimes, and Alignment Healthcare's recent saga has got jaws dropping across trading floors. It's only October, but Alignment's stock took a chilling nosedive on July 8, to the tune of 16.7%, leaving investors wide-eyed and demanding answers. What caused this seismic...

Continue Reading
OriginPoint Boosts Growth with $200M Lender Team

Updated Category News Views 22

Mortgage Powerhouses Join Forces with OriginPoint It's not every day you see a $200 million mortgage team making a beeline for new pastures, but today's landscape seems ripe for such moves. Enter the We Fund LA team, led by mortgage veterans Daniel Arias and Ron Sequeira, as they align with OriginPoint Mortgage to scale new heights in Southern California. This isn't just...

Continue Reading
Bracco's $230M U.S. Expansion: A Strategic Leap

Updated Category News Views 72

Bracco's Bold Move into U.S. Manufacturing In the bustling world of diagnostic imaging, Bracco's latest announcement is like a welcome jolt. They're shelling out $230 million for a new manufacturing facility in Sanford, North Carolina. If you've been around the block in this sector, this move screams ambition—Bracco's playing the long game here. Strategic Location: A...

Continue Reading

Top 5 Most Recently Viewed Articles

The Donors Fund Achieves Significant Milestone in Donations

Updated Category News Views 421

The Donors Fund Reaches a Major Milestone in Giving The Donors Fund is thrilled to share a remarkable update: it has surpassed one billion dollars in total donations since its inception. This achievement firmly establishes it as the leading tech-enabled donor advised fund (DAF) in the field. Such impressive growth can largely be credited to its innovative zero-fee giving...

Continue Reading
Canadians Embrace Homegrown Road Trips, Avoid U.S. Travel

Updated Category News Views 113

Canadians Embrace Local Road Trips for Summer Travel Canadians are gearing up for summer adventures, with a significant majority of motorists planning to explore the scenic routes within their own country. According to new survey data, about 82% of respondents are ready to hit the road for either day excursions or overnight journeys. Interestingly, many are opting to stay...

Continue Reading
Ultra Clean Holdings, Inc. Excels in Financial Performance and Growth

Updated Category News Views 155

Ultra Clean Holdings, Inc. Reports Strong Financial Results Ultra Clean Holdings, Inc. (NASDAQ: UCTT) recently announced its financial results for the fourth quarter and full year. The company achieved remarkable growth, with a total revenue increase of 21 percent compared to the prior year. This performance significantly outperformed trends in the broader semiconductor...

Continue Reading
Legal Troubles: Elon Musk Faces SEC Over Twitter Ownership

Updated Category News Views 478

Elon Musk's SEC Legal Challenge The SEC has brought legal action against Tesla CEO Elon Musk, focusing on his acquisition of Twitter shares. This lawsuit has drawn significant attention, given Musk's high-profile status and his actions surrounding social media. Allegations of Non-Disclosure According to the Securities and Exchange Commission, Musk failed to timely...

Continue Reading
Harnessing Workplace Culture to Enhance Employee Engagement

Updated Category News Views 194

Understanding the Impact of Workplace Culture In today’s competitive landscape, organizations are increasingly facing challenges around talent management and employee experience. Many companies struggle to effectively translate their cultural values into everyday behaviors that align with their strategic goals. Recent case studies from McLean & Company highlight how...

Continue Reading